← FDA DRUG APPROVALS

FDA ANDA · ANDA089370

PROCAINAMIDE HYDROCHLORIDE

Sponsor: IDT AUSTRALIA LTD

APPLICATION
ANDA089370
TYPE
ANDA
ORIGINAL APPROVAL
1987-01-09
LATEST ACTION
1992-01-07
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PROCAINAMIDE HYDROCHLORIDEDiscontinued
PROCAINAMIDE HYDROCHLORIDE 500MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

1992-01-07Labeling · Supplement 9AP
1989-01-23Labeling · Supplement 7AP
1988-11-29Labeling · Supplement 6AP
1987-01-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →